Dutt T, Kashyap R, Surani S. Do we need to screen every patient in intensive care unit for diabetes in community with high prevalence of diabetes? World J Diabetes 2019; 10(3): 137-139 [PMID: 30891149 DOI: 10.4239/wjd.v10.i3.137]
Corresponding Author of This Article
Salim Surani, BSc, FACC, FACP, FCCP, MD, Adjunct Professor, Health Science Center, Texas A and M University, 701 Ayers Street, Corpus Christi, TX 78404, United States. srsurani@hotmail.com
Research Domain of This Article
Critical Care Medicine
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Mar 15, 2019; 10(3): 137-139 Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.137
Do we need to screen every patient in intensive care unit for diabetes in community with high prevalence of diabetes?
Taru Dutt, Rahul Kashyap, Salim Surani
Taru Dutt, Department of Neurology Research, Mayo Clinic, Rochester, MN 55902, United States
Rahul Kashyap, Department of Anesthesiology and Peri-operative Medicine, Critical Care IMP, Mayo Clinic, Rochester, MN 55902, United States
Salim Surani, Health Science Center, Texas A and M University, Corpus Christi, TX 78404, United States
Author contributions: Dutt T, Kashyap R and Surani S contributed to the content writing of the manuscript. Final manuscript draft was approved by all the authors.
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Salim Surani, BSc, FACC, FACP, FCCP, MD, Adjunct Professor, Health Science Center, Texas A and M University, 701 Ayers Street, Corpus Christi, TX 78404, United States. srsurani@hotmail.com
Telephone: +1-361-8857722 Fax: +1-361-8507563
Received: February 9, 2019 Peer-review started: February 10, 2019 First decision: February 19, 2019 Revised: February 27, 2019 Accepted: March 8, 2019 Article in press: March 8, 2019 Published online: March 15, 2019 Processing time: 34 Days and 2.6 Hours
Abstract
Diabetes mellitus (DM) is marked as global health care challenge with almost 10% of the United States population being diagnosed with DM. A sizeable percentage of patients are oblivious of their disease, in spite of easily accessibility knowledge about its early signs and symptoms and rapid diagnostic modalities. Critically ill patients with undiagnosed DM are likely to have an increased mortality as compared to intensive care unit (ICU) patients with diagnosed DM. DM may have adverse effect on ICU patients causing organ failure and complications. Early Screening of patients at the risk of developing disease may prevent long term complications. Early screening and management may be beneficial as controlled DM patients have similar morbidity as non DM patients in ICU. An intense glycaemic and blood pressure control improves retinopathy and albuminuria, but may not affect the macrovascular outcomes.
Core tip: Undiagnosed diabetes mellitus (DM) predisposes critically ill patients to DM complications, which may affect their morbidity and mortality during intensive care unit stay.
